The latest regulatory clearance is expected to significantly strengthen Masimo’s patient monitoring business on a global scale. Per Masimo, the Masimo W1 medical watch has been developed to be ...
"We are united in our enthusiasm for Masimo’s future as a leading, innovation-focused growth company," the newest board ...
Masimo Corporation MASI, on Friday, announced a partnership with Google. The tie-up aims to develop a new reference platform ...
Masimo shareholders today will decide on a bitter proxy fight between the company's founder and CEO Joe Kiani and Politan ...
Masimo announced a partnership with Google to develop a comprehensive smartwatch reference platform for OEMs building Wear OS ...
User-friendly touch-screen patient monitor measures ECG, SpO 2, NIBP, heart rate, temperature and respiration. Offers optional dual IBP, and EtCo 2 — Now with Masimo SET ® Pulse Oximetry!
Masimo (MASI – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Vik Chopra from ...
In 2013, Masimo introduced the Root® Patient Monitoring and Connectivity Platform, built from the ground up to be as flexible and expandable as possible to facilitate the addition of other Masimo ...
Masimo is partnering with Qualcomm Technologies to develop a comprehensive reference platform to expand the Wear OS by Google™ ecosystem.
Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI), a global leader in noninvasive monitoring technologies and audio products, today is sharing a summary of the core issues to consider in ...
Masimo is urging stockholders to vote “FOR” the Company’s director nominees, Joe Kiani and Christopher Chavez, on the updated GOLD proxy card to protect the Company and the value of their investment.